Image (2d6a3b2a 08f3 432d 8fdf B554410153b6 1830 2)
Divalproex Sodium Tablet, Delayed Release
Product Images NDC 72162-2460
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 72162-2460). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (D405e38e 5f4d 4977 B36b Fca8c23cf294 01)
Chemical structure of divalproex sodium is shown, depicting the molecular arrangement including sodium ions and organic groups characteristic of this active ingredient.*
Image (D405e38e 5f4d 4977 B36b Fca8c23cf294 02)
A bar graph comparing percentage results between placebo (PBO) and Divalproex Sodium (DVPX) treatments across two studies. Study 1 (YMRS) shows 26% for PBO and 60% for DVPX, while Study 2 (IMRS) shows 29% for PBO and 58% for DVPX.*
Image (D405e38e 5f4d 4977 B36b Fca8c23cf294 03)
A comparative curve chart showing the percentage reduction in CPS rate versus percentage of patients for Divalproex Sodium and placebo. The y-axis represents improvement or worsening in CPS rate, while the x-axis shows the percentage of patients. The solid line represents Divalproex Sodium and the dashed line represents placebo.*
Image (D405e38e 5f4d 4977 B36b Fca8c23cf294 04)
A line chart illustrating the percentage reduction in CPS rate versus the percentage of patients for Divalproex Sodium. The chart compares high dose (solid line) and low dose (dashed line), showing patient improvement or worsening based on dose.*
Image (D405e38e 5f4d 4977 B36b Fca8c23cf294 05)
A bar graph comparing two studies showing data for Placebo and Divalproex Sodium groups. Each study has two bars representing the results for Placebo and Divalproex Sodium, but no specific variables or values are given beyond the visual bar heights.*
Label (Lbl721622460)
Label for Divalproex Sodium Delayed Release Tablets USP, 250 mg strength, in a package containing 100 tablets. The label includes the NDC 72162-2460-1, and identifies Bryant Ranch Prepack as the relabeler, with manufacturing by Unichem Laboratories Ltd. Storage instructions and QR codes for prescribing information and package insert are also present.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
